Schon Pharmaceuticals Limited, a active public limited company, was established on 30 September 1994 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231MP1994PLC007829. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.23 Cr.
Formerly known as Schon Pharmaceuticals Private Limited. It upholds a compliant status. Employing 77 professional, Its leadership includes Anil Bhatia (Director), Rekha Bhatia (Director), Sunil Bhatia (Director). Past directors included Surender Radhakrishnani Lachmandas, Pooja Bhatia. It holds ₹30.46 Cr open charges and ₹20.65 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 145/2-A-B, Jambudi Hapsi Hatod Road, Indore, Madhya Pradesh, 453112.
U24231MP1994PLC007829
007829
30 September 1994
₹1.25 Cr
₹1.23 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Schon Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Bhatia | Director | 30 Sep 1994 | Current |
| Rekha Bhatia | Director | 30 Sep 1994 | Current |
| Sunil Bhatia | Director | 30 Sep 1994 | Current |
| Pooja Bhatia | Director | 28 Aug 2023 | Current |
| Prashant Singh | Director | 01 Apr 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Schon Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 6.94% increase. The company also saw a slight improvement in profitability, with a 0.91% increase in profit. The company's net worth moved up by a moderate rise of 6.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Schon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹304,600,000.00
₹206,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2025 | Sidbi | ₹1.10 Cr | Open |
| 23 Jan 2024 | Sidbi | ₹3.96 Cr | Open |
| 11 Jan 2022 | Sidbi | ₹2.00 Cr | Open |
| 26 Oct 2018 | Axis Bank Limited | ₹23.40 Cr | Open |
| 19 Nov 2015 | Kotak Mahindra Bank Limited | ₹8.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Schon Pharmaceuticals has a workforce of 77 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Schon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Schon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited of Rs. 23.40 Cr registered on 26 Oct 2018 with Charge ID 100220359 was modified on 14 Oct 2025. was recorded as a recent event.
Progress on A charge with Sidbi amounted to Rs. 1.10 Cr with Charge ID 101060896 was registered on 28 Feb 2025. was documented.
Schon Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Schon Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.
Progress on A charge with Sidbi amounted to Rs. 3.96 Cr with Charge ID 100853535 was registered on 23 Jan 2024. was documented.
The activity Pooja Bhatia was appointed as a Director was appointed as a Director on 28 Aug 2023 & has been associated with this company since 2 years 3 months . was completed.
The CIN of Schon Pharmaceuticals Limited is U24231MP1994PLC007829.
Schon Pharmaceuticals Limited is headquartered at 145/2-A-B, Jambudi Hapsi Hatod Road, Indore, Madhya Pradesh, 453112.
Schon Pharmaceuticals Limited was incorporated on 30 September 1994.
The current directors of Schon Pharmaceuticals Limited are
The primary industry of Schon Pharmaceuticals Limited is Manufacturing.
Schon Pharmaceuticals Limited is unlisted.
The authorized capital of Schon Pharmaceuticals Limited is ₹1.25 Cr, and the paid-up capital is ₹1.23 Cr.
The compliance status of Schon Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX